packageVelmanaseAlfa

velmanase alfa

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Velmanase alfa is an enzyme replacement therapy used to treat alpha-mannosidosis, a rare inherited metabolic disorder. It is authorised in the European Union under the brand name Lamazym.

Summary written by glm-5.3-flash from Wikidata Q98651803 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:velmanase alfa
ATC codes:A16AB15
DrugBank:DB12374
Wikidata:Q98651803
molar mass:65.4 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown